Ladder Bio
Health
· Headquartered in N/A 🌍
Track Ladder Bio
— get Health deals in free daily digest
Overview
Ladder Bio Inc., formerly thirdlaw molecular, secured $5.5 million in a seed financing round led by Medical Excellence Capital, with participation from Hatch Biofund. The company develops spiroligomer therapeutics aimed at addressing "undruggable" targets, combining the benefits of biologics and small molecules.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Medical Excellence Capital, Hatch Biofund
Ladder Bio Inc., formerly thirdlaw molecular, secured $5.5 million in a seed financing round led by Medical Excellence Capital, with participation from Hatch Biofund. The company develops spiroligomer therapeutics aimed at addressing "undruggable" targets, combining the benefits of biologics and small molecules.